inVentiv Health Clinical

Recent papers from inVentiv Health Clinical

1. Transparency Through Testing: Rethinking Certification and Safety in Personal Care ProductsStandards · 2026
2. Optimization of the Nanoparticle Yield and Physicochemical Properties by a Structured Study of Nanoprecipitation Process ParametersACS Omega · 2026
3. A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19Infectious Diseases and Therapy · 2026
4. Theoretical Framework for Physical-Layer Encryption via Quantized Vacuum Harmonic Modes2026
5. Immunobridging for Pemivibart, a Monoclonal Antibody for Prevention of Covid-19New England Journal of Medicine · 2024
6. Abstract PO4-15-12: Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancerCancer Research · 2024
7. St. Louis Enhancing Engagement and Retention in HIV/AIDS Care (STEER): a participatory intersectional needs assessment for intervention and implementation planning2024
8. “They need people to actually show up in their lives:” deploying community health workers to improve mental health and substance use outcomes among PLWHJournal of HIV/AIDS & Social Services · 2023
9. Phenotypic screening models for rapid diagnosis of genetic variants and discovery of personalized therapeuticsMolecular Aspects of Medicine · 2022
10. Systems to model the personalized aspects of microbiome health and gut dysbiosisMolecular Aspects of Medicine · 2022
11. Inter-species geographic signatures for tracing horizontal gene transfer and long-term persistence of carbapenem resistanceGenome Medicine · 2022
12. Inter-species geographic signatures for tracing horizontal gene transfer and long-term persistence of carbapenem resistance2021
13. Platforms for Personalized Polytherapeutics Discovery in COVID-19Journal of Molecular Biology · 2021
14. 11th GCC Closed Forum: Cumulative Stability; Matrix Stability; Immunogenicity assays; Laboratory Manuals; Biosimilars; Chiral methods; Hybrid LBA/LCMS Assays; Fit-for-Purpose Validation; China Food and Drug Administration Bioanalytical Method ValidationBioanalysis · 2018
15. Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in JapanJournal of Atherosclerosis and Thrombosis · 2018
16. Measuring the cost of a pediatric vaccine administration in the UKVaccine · 2017
17. 2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays)Bioanalysis · 2017
18. Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ StudyJournal of Bone and Mineral Research · 2017
19. Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA StudyJournal of Bone and Mineral Research · 2017
20. Bayesian Forecasting Tool to Predict the Need for Antidote in Acute Acetaminophen OverdosePharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2017